A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy

Lignende værker

• Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
  af: Clem, James R, et al.
  Udgivet: (2009)
• Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
  af: James R Clem, et al.
  Udgivet: (2009-12-01)
• Increased Rosuvastatin Dose versus Concomitant Fenofibrate and Rosuvastatin Therapy to Achieve Lipid Goal in Patients with Diabetes or Atherosclerosis with Metabolic Syndrome
  af: Chen, Yeh-Peng, et al.
  Udgivet: (2013)
• Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus
  af: Rosenson, Robert S., et al.
  Udgivet: (2010)
• A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations
  af: Ling, Hua, et al.
  Udgivet: (2013)